Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 75
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Davis, Dena S. 2016. Genetic Testing as Part of a Plan for Preemptive Suicide in the Face of Impending Dementia. Current Genetic Medicine Reports,

    Kazim, Syed Faraz and Iqbal, Khalid 2016. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease. Molecular Neurodegeneration, Vol. 11, Issue. 1,

    Masliah, Eliezer and Salmon, David P. 2016. Genes, Environment and Alzheimer's Disease.

    Balardin, Joana B. Batistuzzo, Marcelo C. Martin, Maria da Graça Moraes Sato, João R. Smid, Jerusa Porto, Claudia Savage, Cary R. Nitrini, Ricardo Amaro, Edson and Miotto, Eliane C. 2015. Differences in prefrontal cortex activation and deactivation during strategic episodic verbal memory encoding in mild cognitive impairment. Frontiers in Aging Neuroscience, Vol. 7,

    Cloutier, Simon Chertkow, Howard Kergoat, Marie-Jeanne Gauthier, Serge Belleville, Sylvie and Bondi, Mark 2015. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment. Journal of Alzheimer's Disease, Vol. 47, Issue. 4, p. 901.

    Elkana, Odelia Eisikovits, Osnat Reichman Oren, Noga Betzale, Vered Giladi, Nir Ash, Elissa L. and Gozes, Illana 2015. Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up. Journal of Alzheimer's Disease, Vol. 49, Issue. 3, p. 607.

    Hassenstab, Jason Monsell, Sarah E. Mock, Charles Roe, Catherine M. Cairns, Nigel J. Morris, John C. and Kukull, Walter 2015. Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology. Journal of Neuropathology & Experimental Neurology, Vol. 74, Issue. 11, p. 1086.

    Kuzmickienė, Jurgita and Kaubrys, Gintaras 2015. Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease. Medical Science Monitor, Vol. 21, p. 2572.

    Mistridis, Panagiota Krumm, Sabine Monsch, Andreas U. Berres, Manfred Taylor, Kirsten I. and Benke, Thomas 2015. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer’s Disease: The Temporal Emergence of Cognitive Decline. Journal of Alzheimer's Disease, Vol. 48, Issue. 4, p. 1095.

    Rajan, Kumar B. Wilson, Robert S. Weuve, Jennifer Barnes, Lisa L. and Evans, Denis A. 2015. Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia. Neurology, Vol. 85, Issue. 10, p. 898.

    Sohrabi, Hamid R. Bates, Kristyn A. Weinborn, Michael Bucks, Romola S. Rainey-Smith, Stephanie R. Rodrigues, Mark A. Bird, Sabine M. Brown, Belinda M. Beilby, John Howard, Matthew Criddle, Arthur Wraith, Megan Taddei, Kevin Martins, Georgia Paton, Athena Shah, Tejal Dhaliwal, Satvinder S. Mehta, Pankaj D. Foster, Jonathan K. Martins, Ian J. Lautenschlager, Nicola T. Mastaglia, Francis Laws, Simon M. and Martins, Ralph N. 2015. Bone mineral density, adiposity, and cognitive functions. Frontiers in Aging Neuroscience, Vol. 7,

    Davis, Dena S 2014. Alzheimer disease and pre-emptive suicide. Journal of Medical Ethics, Vol. 40, Issue. 8, p. 543.

    Gawron, Natalia Łojek, Emilia Kijanowska-Haładyna, Beata Nestorowicz, Jakub Harasim, Andrzej Pluta, Agnieszka and Sobańska, Marta 2014. Cognitive Patterns of Normal Elderly Subjects Are Consistent With Frontal Cortico-Subcortical and Fronto-Parietal Neuropsychological Models of Brain Aging. Applied Neuropsychology: Adult, Vol. 21, Issue. 3, p. 195.

    Lindbergh, C. A. Puente, A. N. Gray, J. C. Mackillop, J. and Miller, L. S. 2014. Delay and Probability Discounting as Candidate Markers for Dementia: An Initial Investigation. Archives of Clinical Neuropsychology, Vol. 29, Issue. 7, p. 651.

    Lundervold, Astri J. Wollschläger, Daniel and Wehling, Eike 2014. Age and sex related changes in episodic memory function in middle aged and older adults. Scandinavian Journal of Psychology, Vol. 55, Issue. 3, p. 225.

    Monti, Jim M. Balota, David A. Warren, David E. and Cohen, Neal J. 2014. Very mild Alzheimer׳s disease is characterized by increased sensitivity to mnemonic interference. Neuropsychologia, Vol. 59, p. 47.

    Overdorp, Eduard J. Kessels, Roy P. C. Claassen, Jurgen A. and Oosterman, Joukje M. 2014. Cognitive impairments associated with medial temporal atrophy and white matter hyperintensities: an MRI study in memory clinic patients. Frontiers in Aging Neuroscience, Vol. 6,

    Rushing, Nicole C. Sachs-Ericsson, Natalie and Steffens, David C. 2014. Neuropsychological indicators of preclinical Alzheimer’s disease among depressed older adults. Aging, Neuropsychology, and Cognition, Vol. 21, Issue. 1, p. 99.

    Aurtenetxe, Sara Castellanos, Nazareth P. Moratti, Stephan Bajo, Ricardo Gil, Pedro Beitia, Garikoitz del-Pozo, Francisco and Maestú, Fernando 2013. Dysfunctional and compensatory duality in mild cognitive impairment during a continuous recognition memory task. International Journal of Psychophysiology, Vol. 87, Issue. 1, p. 95.

    Azuma, Tamiko Sabbagh, Marwan N. and Connor, Donald J. 2013. The effect of healthy aging and mild cognitive impairment on semantic ambiguity detection. Journal of Neurolinguistics, Vol. 26, Issue. 2, p. 271.

  • Journal of the International Neuropsychological Society, Volume 12, Issue 5
  • September 2006, pp. 707-735

Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease

  • DOI:
  • Published online: 01 September 2006

Alzheimer's disease (AD) is a common, devastating form of dementia. With the advent of promising symptomatic treatment, the importance of recognizing AD at its very earliest stages has increased. We review the extant neuropsychological and neuroimaging literature on preclinical AD, focusing on longitudinal studies of initially nondemented individuals and cross-sectional investigations comparing at-risk with normal individuals. We systematically reviewed 91 studies of neuropsychological functioning, structural neuroimaging, or functional neuroimaging in preclinical AD. The neuropsychological studies indicated that preclinical AD might be characterized by subtle deficits in a broad range of neuropsychological domains, particularly in attention, learning and memory, executive functioning, processing speed, and language. Recent findings from neuroimaging research suggest that volume loss and cerebral blood flow or metabolic changes, particularly in the temporal lobe, may be detected before the onset of dementia. There exist several markers of a preclinical period of AD, in which specific cognitive and biochemical changes precede the clinical manifestations. The preclinical indicators of AD reflect early compromise of generalized brain integrity and temporal lobe functioning in particular. (JINS, 2006, 12, 707–735.)

Corresponding author
Correspondence and reprint requests to: Elizabeth W. Twamley, Ph.D., University of California, San Diego, Department of Psychiatry, 9500 Gilman Drive (0851), La Jolla, CA 92093. E-mail:
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of the International Neuropsychological Society
  • ISSN: 1355-6177
  • EISSN: 1469-7661
  • URL: /core/journals/journal-of-the-international-neuropsychological-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *